Canopy Growth Corporation

TSX:WEED Stock Report

Market Cap: CA$1.2b

Canopy Growth Past Earnings Performance

Past criteria checks 0/6

Canopy Growth's earnings have been declining at an average annual rate of -21.3%, while the Pharmaceuticals industry saw earnings growing at 26.2% annually. Revenues have been growing at an average rate of 6.2% per year.

Key information

-21.3%

Earnings growth rate

-11.5%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate6.2%
Return on equity-221.4%
Net Margin-325.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%

Feb 23
More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%

Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Feb 13
Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report

Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge

Dec 22
Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge

Is Canopy Growth (TSE:WEED) A Risky Investment?

Sep 17
Is Canopy Growth (TSE:WEED) A Risky Investment?

With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For

Apr 17
With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Mar 21
Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 12
Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts

Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Dec 08
Is Canopy Growth (TSE:WEED) Using Too Much Debt?

Revenue & Expenses Breakdown
Beta

How Canopy Growth makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSX:WEED Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23362-1,1803520
30 Sep 23369-1,1723860
30 Jun 23387-1,2214270
31 Mar 23403-3,2784550
31 Dec 22367-3,0514010
30 Sep 22423-2,9384450
30 Jun 22466-2,7665170
31 Mar 22510-3105520
31 Dec 21557-4285880
30 Sep 21569-1,2236160
30 Jun 21572-1,2446190
31 Mar 21547-1,7456640
31 Dec 20506-2,3487650
30 Sep 20477-1,5358430
30 Jun 20419-1,2449380
31 Mar 20399-1,3219930
31 Dec 19385-415961-5
30 Sep 19344-2568810
30 Jun 19291-8327940
31 Mar 19226-7366420
31 Dec 18155-3984704
30 Sep 1894-464350-1
30 Jun 1888-1481990
31 Mar 1878-671490
31 Dec 1770-21950
30 Sep 1758-19661
30 Jun 1749-13501
31 Mar 1740-8391
31 Dec 1630-1292
30 Sep 1624-7251
30 Jun 1618-8211
31 Mar 1613-3171
31 Dec 1580130
30 Sep 1561110
30 Jun 153-5100
31 Mar 152-780
31 Dec 141-970
30 Sep 141-750

Quality Earnings: WEED is currently unprofitable.

Growing Profit Margin: WEED is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: WEED is unprofitable, and losses have increased over the past 5 years at a rate of 21.3% per year.

Accelerating Growth: Unable to compare WEED's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WEED is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (100.1%).


Return on Equity

High ROE: WEED has a negative Return on Equity (-221.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.